Chemoinformaics analysis of (R)-(-)-(Z)-14-METHYL-8-HEXADECEN-1-OL
| Molecular Weight | 254.458 | nRot | 13 |
| Heavy Atom Molecular Weight | 220.186 | nRig | 1 |
| Exact Molecular Weight | 254.261 | nRing | 0 |
| Solubility: LogS | -6.17 | nHRing | 0 |
| Solubility: LogP | 6.611 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 51.863 |
| nHD | 1 | BPOL | 34.109 |
| QED | 0.341 |
| Synth | 2.691 |
| Natural Product Likeliness | 1.401 |
| NR-PPAR-gamma | 0.084 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.008 |
| HIA | 0.004 |
| CACO-2 | -4.495 |
| MDCK | 0.000013 |
| BBB | 0.196 |
| PPB | 0.971635 |
| VDSS | 2.923 |
| FU | 0.0196758 |
| CYP1A2-inh | 0.821 |
| CYP1A2-sub | 0.196 |
| CYP2c19-inh | 0.393 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.376 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.06 |
| CYP3a4-inh | 0.293 |
| CYP3a4-sub | 0.059 |
| CL | 7.89 |
| T12 | 0.187 |
| hERG | 0.077 |
| Ames | 0.005 |
| ROA | 0.01 |
| SkinSen | 0.96 |
| Carcinogencity | 0.058 |
| EI | 0.949 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.101 |
| Antiviral | Yes |
| Prediction | 0.748932 |